GSK3B and diabetes mellitus: The GSK3β inhibitors so far designed for the treatment of infectious and non-infectious diseases such as diabetes, cancer, and neurodegenerative disorders have not been fully successful mainly because GSK3β is embedded in multi-protein complexes, which makes the access of inhibitory compounds difficult.